QPPV Responsibilities

The Qualified Person Responsible for Pharmacovigilance (QPPV) is responsible for oversight of the marketing authorisation holder's pharmacovigilance system and acts as the central point of pharmacovigilance responsibility within the organisation.

Overview

The QPPV role extends beyond operational pharmacovigilance activities. The position is primarily an oversight and governance role focused on ensuring that the pharmacovigilance system operates effectively, remains compliant and is capable of meeting regulatory expectations.

While day-to-day activities may be delegated to specialists, vendors or service providers, responsibility for oversight of the pharmacovigilance system remains with the QPPV.

Oversight of the Pharmacovigilance System

One of the core responsibilities of the QPPV is to maintain oversight of the pharmacovigilance system.

This includes maintaining awareness of the structure, processes, responsibilities and controls that support pharmacovigilance activities throughout the organisation.

The QPPV should be able to understand how safety information is collected, evaluated, escalated and reported within the pharmacovigilance system.

Pharmacovigilance System Master File (PSMF)

The QPPV is expected to maintain awareness of the content, location and operation of the Pharmacovigilance System Master File (PSMF).

The PSMF provides a detailed description of the pharmacovigilance system and is a key document reviewed during inspections and regulatory assessments.

Although individual sections may be maintained by different functions, the QPPV should remain familiar with the overall content and status of the document.

Inspection Readiness

Regulatory authorities may inspect the pharmacovigilance system to evaluate compliance with applicable requirements.

QPPVs are frequently involved in inspection preparation, inspection management, responses to observations and oversight of corrective and preventive actions.

Maintaining inspection readiness is generally considered an ongoing activity rather than a task performed only before inspections.

Awareness of Product Safety Issues

QPPVs are expected to maintain awareness of significant safety concerns affecting products within the scope of their responsibility.

This may include emerging safety signals, important identified risks, ongoing regulatory commitments, risk minimisation activities and significant compliance issues.

The exact mechanisms used to maintain awareness vary between organisations but typically involve governance meetings, escalation processes and safety review forums.

Vendor and Partner Oversight

Many pharmacovigilance activities are delegated to contract research organisations, vendors and service providers.

Delegation of activities does not remove the need for appropriate oversight. QPPVs are often expected to understand how outsourced activities are governed, monitored and controlled.

Governance and Escalation

An important aspect of the role involves ensuring that significant pharmacovigilance issues are appropriately escalated within the organisation.

QPPVs often participate in governance structures that allow safety concerns, compliance risks and inspection findings to be communicated to senior management.

Interactions with Regulatory Authorities

The QPPV serves as an important pharmacovigilance contact point for regulatory authorities.

Depending on the situation, interactions may involve inspection activities, requests for information, regulatory commitments, safety concerns or discussions related to the pharmacovigilance system.

Practical Perspective

In practice, experienced QPPVs often spend less time performing operational pharmacovigilance activities and more time focusing on oversight, governance, quality, inspection readiness and organisational risk management.

The role requires both pharmacovigilance expertise and the ability to maintain visibility across complex processes involving multiple departments, vendors and stakeholders.

Related Guides

Last reviewed: June 2026